Treating Nicotine Dependence in Schizophrenic Individuals: Effectiveness of Bupropion – 1
Condition(s):Tobacco Use Cessation; Tobacco Use Disorder; SchizophreniaLast Updated:January 12, 2017Completed
Hide Studies Not Open or Pending
Condition(s):Tobacco Use Cessation; Tobacco Use Disorder; SchizophreniaLast Updated:January 12, 2017Completed
Condition(s):Smoking Cessation; Smoking, Tobacco; Mental Illness; Tobacco Use DisorderLast Updated:September 18, 2023Recruiting
Condition(s):Nicotine DependenceLast Updated:June 27, 2006Completed
Condition(s):Major Depressive Disorder (MDD)Last Updated:March 29, 2011Completed
Condition(s):Major Depressive Disorder (MDD)Last Updated:October 4, 2010Completed
Condition(s):Attention Deficit DisorderLast Updated:February 12, 2013Completed
Condition(s):Obesity; OverweightLast Updated:December 29, 2015Completed
Condition(s):Seasonal Affective DisorderLast Updated:January 23, 2017Completed
Condition(s):Tobacco Use DisorderLast Updated:May 21, 2018Completed
Condition(s):Healthy SubjectsLast Updated:November 3, 2015Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.